Crews to shore up roof at 2-year-old Palladium

April 11, 2013
Back to TopCommentsE-mailPrintBookmark and Share

PalladiumSpring performances at Carmel’s 2-year-old Palladium are not expected to be affected by interior construction work at the venue set to begin in mid-April.

The $140,000 project, managed by Indianapolis-based contractor Shiel Sexton on behalf of the Carmel Redevelopment Commission, should last about three weeks.

Construction of the $119 million city-owned concert hall was halted in mid-2009 after an inspection revealed a rip in the structural steel supporting the venue’s signature domed roof. Work resumed after extensive repairs, and the city in 2011 sued Michigan-based contractor Steel Supply & Engineering Co. for breach of contract and negligence.

The new roof work was recommended during a review conducted as part of the ongoing litigation, according to a city news release. Community relations spokeswoman Melanie Lentz declined to answer questions about the project, citing the pending lawsuit.
 
Crews will retrofit the roof trusses, the release said, welding additional stiffeners and small plates in place.

The Palladium is the centerpiece of the three-venue Center for the Performing Arts. IBJ reported last month that the theaters sold about 145,000 tickets during the 2011-2012 season.

ADVERTISEMENT
  • Not understanding the cost??
    If this is a breach of contract/negligence issue with the steel supplier, why is the full cost not being borne by them? Shouldn't a 2-yr old building be fully covered by insurance or a warranty? The taxpayers should not have to foot this bill.
    • Who Knows?
      One never knows what the real story is in Carmel so who knows what the real deal is with this situation. And we'll never know unless the situation reaches critical mass such as when the Carmel Redevelopment Commission became insolvent and then the citizens of Carmel had to bail them out to the tune of $200 million.
    • Mitigation
      Because a party has a duty to mitigate its damages.

    Post a comment to this blog

    COMMENTS POLICY
    We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
     
    You are legally responsible for what you post and your anonymity is not guaranteed.
     
    Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
     
    No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
     
    We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
     

    Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

    Sponsored by
    ADVERTISEMENT
    1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

    2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

    3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

    4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

    5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?

    ADVERTISEMENT